Analysis haemostatic system gene polymorphism in pregnant women without complications from Russia and Ukraine
- Authors: Vashukova E.S1, Glotov A.S1, Kanaeva M.D2, Polushkina L.B1, Shabanova N.A1, Tatarsky P.F3, Nosenko E.N4, Mertil B.4, Zhabchenko I.A5, Pokhitun M.V5, Livshits L.A3, Zainulina M.S1, Baranov V.S1
-
Affiliations:
- D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology , Saint-Petersburg, RF
- Saint-Petersburg State University., Saint-Petersburg, RF
- Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine
- Maxim Gorky Donetsk National Medical University, Donetsk, Ukraine
- Institute of Pediatrics, Obstetrics and Gynecology NAMSU, Kyiv, Ukraine
- Issue: Vol 9, No 1 (2011)
- Pages: 70-80
- Section: Articles
- URL: https://journals.rcsi.science/ecolgenet/article/view/5745
- DOI: https://doi.org/10.17816/ecogen9170-80
- ID: 5745
Cite item
Full Text
Abstract
Keywords
About the authors
Elena S Vashukova
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology , Saint-Petersburg, RF
Email: vi_lena@list.ru 199034, Saint-Petersburg, Mendeleyevskaya line, 3, Russia
Andrey S Glotov
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology , Saint-Petersburg, RF
Email: anglotov@mail.ru 199034, Saint-Petersburg, Mendeleyevskaya line, 3, Russia
Maria D Kanaeva
Saint-Petersburg State University., Saint-Petersburg, RF
Email: kanaeva.masha@yandex.ru 199034, Saint-Petersburg, Universitetskaya nab, 7/9, Russia
Lubov B Polushkina
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology , Saint-Petersburg, RF
Email: iagmail@ott.ru
Nadezhda A Shabanova
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology , Saint-Petersburg, RF
Email: iagmail@ott.ru
Pavel F Tatarsky
Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine
Email: livshits@imbg.org.ua
Elena N Nosenko
Maxim Gorky Donetsk National Medical University, Donetsk, Ukraine
Email: iagmail@ott.ru
Beshir Mertil
Maxim Gorky Donetsk National Medical University, Donetsk, Ukraine
Email: babich@mama.dn.ua
Irina A Zhabchenko
Institute of Pediatrics, Obstetrics and Gynecology NAMSU, Kyiv, Ukraine
Marina V Pokhitun
Institute of Pediatrics, Obstetrics and Gynecology NAMSU, Kyiv, Ukraine
Ludmila A Livshits
Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine
Email: livshits@imbg.org.ua
Marina S Zainulina
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology , Saint-Petersburg, RF
Email: 199034, Russia, Saint Petersburg, 3, Mendeleyevskaya line
Vladislav S Baranov
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology , Saint-Petersburg, RF
Email: baranov@vb2475.spb.edu
References
- Баранов В. С., Баранова Е. В., Иващенко Т. Э. и др., 2000. Геном человека и гены «предрасположенности». Введение в предиктивную медицину. СПб.: Интермедика. 272 с.
- Вашукова Е. С., Глотов А. С., Иващенко Т. Э. и др., 2008. Современные подходы к диагностике наследственных форм тромбофилии//Российский педиатрический журнал. № 5. С. 48-53.
- Глотов А. С., Иващенко Т. Э., Образцова Г. И. и др., 2007. Зависимость между возникновением стабильной артериальной гипертензии у детей и полиморфизмом генов ренин-ангиотензиновой и кинин-брадики-ниновой систем на формирование//Молекулярная биология. Т. 41. № 1. С. 18-25.
- Глотов О. С., Глотов А. С., Тарасенко О. А. и др., 2004. Исследование функционально-значимого полиморфизма ACE, AGTR1, eNOS, MTHFR, MTRR и APOE генов в популяции Северо-Западного региона России//Экологическая генетика. Т. 2. № 3. С. 32-35.
- Долгушина Н. В., 2009. Патогенез и профилактика плацентарной недостаточности и синдрома потери плода у беременных с вирусными инфекциями: Автореф. дис. докт. мед. наук. Москва. 48 с.
- Зайнулина М. С., Корнюшина Е. А., Мозговая М. Л. и др., 2005. Тромбофилия в акушерской практике: учебно-методическое пособие/под ред. Э. К. Айламазяна, Н. Н. Петрищева. СПб.: Издательство Н-Л. 46 с.
- Капустин C. И., 2007. Молекулярно-генетические аспекты патогенеза венозного тромбоэмболизма: Автореф. дис. докт. мед. наук. СПб, 294 с.
- Макацария А. Д., Бицадзе В. О., 2006. Антифосфолипидный синдром, генетические тромбофилии в патогенезе основных форм акушерской патологии//РМЖ. Специальный выпуск. С. 2-11.
- Малышева О. В., Беспалова О. Н., Иващенко Т. Э. и др., 2007. Невынашивание беременности и полиморфизм генов системы свертывания крови//Журнал акушерства и женских болезней. Т. LVI. № 1. С. 21-27.
- Маниатис Т., Фрич Э., Сэмбрук Д., 1984. Молекулярное клонирование. -М.: Мир, 480 с.
- Москаленко М. В., Асеев М. В., Котова С. М. и др., 2004. Анализ ассоциации аллелей генов Col1A1, VDR и CALRC с развитием остеопороза//Экологическая генетика. Т. 2. № 1. С. 38-43.
- Спиридонова М. Г., Трифонова Е. А., Фадюши-на С. В. и др., 2007. Молекулярно-генетический анализ полиморфных маркеров генов, ответственных за функционирование факторов эндотелиальной системы в связи с осложненным течением беременности//Медицинская генетика. Т. 6. № 7. Вып. 61. С. 38-42.
- Фаворова О. О., Николаева Т. Я., Чугунова С. А. и др., 2007. Вклад генетических факторов в развитие артериальной гипертонии при разных типах инсуль-та у якутов//Кардиологический вестник. Т. 02. № 1. URL: http://www.consiliummedicum.com/magazines/magazines/cardio/cardiology/article/7238.
- Bertina R. M., Koeleman B. P., Koster T. et al., 1994. Mutation in blood coagulation factor V associated with resistance to activated protein C//Nature. Vol. 369. N 6475. P. 64-67.
- Camilleri R. S., Peebles D., Portmann C. et al., 2004. -455G/A b-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications//Blood Coagulation and Fibrinolysis. Vol. 15 N 2. P. 139-147.
- Cappuccio F., Bell R., Perry I. et al., 2002. Homocysteine levels in men and women of different ethnic and cultural background living in England.//Atherosclerosis. V. 164. N. 1. P. 95-102.
- Cook D. G., Cappuccio F. P., Atkinson R. W. et al., 2001. Ethnic differences in fibrinogen levels: the role of environmental factors and the β-fibrinogen gene//American Journal of Epidemiology. V. 153. N. 8. P. 799-806.
- Dekker G. A., de Vries JI. P., Doelitzsch P. M. et al., 1995. Underlying disorders associated with severe earlyonset preeclampsia//Am. J. Obstet. Gynecol. Vol. 173. P. 1042-1048.
- Fabbro D., D'Elia A. V., Spizzo R. et al., 2003. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia//Gynecol Obstet Invest. Vol. 56. P. 17-22.
- Gehring N. H., Frede U., Neu-Yilik G., 2001. Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia//Nature Genet. V. 28. P. 389-392.
- Gerhardt A., Goecke T. W., Beckmann M. W. et al, 2005. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia//J Thrombosis and Haemostasis. Vol. 3. P. 686-691.
- Hakli T., Romppanen E. -L., Hiltunen M. et al., 2003. Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia//Genetic testing. Vol. 7. N. 3. P. 265-268.
- Hiltunen L. M., Laivuori H., Rautanen A. et al., 2009. Factor V Leiden as risk factor for unexplained stillbirth -a population-based nested case-control study//Thrombosis Research (in press).
- Honda S., Honda Y., Bauer B. et al., 1995. The impact of three-dimensional structure on the expression of PlA alloantigens on human integrin beta 3//Blood. Vol. 86. P. 234-242.
- Kupferminc M. J. Eldor A., Steinman N. et al., 1999. Increased frequency of genetic thrombophilia in women with complications of pregnancy//N. Engl. J. Med. Vol. 340. N. 1. P. 9-13.
- Kupferminc M. J., 2005. Thrombophilia and pregnancy//Curr Pharm Des. Vol. 11. N 6. P. 735-748.
- Laasanen J., Hiltunen M., Punnonen K. et al., 2002. Fibrinogen and factor VII promoter polymorphisms in women with preeclampsia//Obstetrics & Gynecology. Vol. 100, N. 2. P. 317-320.
- Lane D. A., Grant P. J., 2000. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease//Blood. Vol. 95. N 5. P. 1517-1532.
- Libert F., Cochaux P., Beckman G. et al., 1998. The Δccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe//Human Molecular Genetics. V. 7. N 3. P. 399-406.
- Lin J., August P., 2005. Genetic Thrombophilias and Preeclampsia: a meta-analysis//Obstetrics & Gynecology. Vol. 105. P. 182-192.
- Limborska S. A., Balanovsky O. P., Balanovskaya E. V. et al., 2002. Analysis of CCR5Δ32 geographic distribution and its correlation with some climatic and geographic factors//Hum Hered. Vol. 53. P. 49-54.
- Mello G., Parretti E., Marozio L. et al., 2005. Thrombophilia is significantly associated with severe preeclampsia Results of a large-scale, case-controlled study//Hypertension. Vol. 46. P. 1270-1274.
- Miller S. A., Dykes D. D., Polesky H. F., 1988. A simple salting out procedure for extracting DNA from human nucleated cells//Nucleic Acids Research. Vol. 16. N 3. P. 1215.
- O'Shaughnessy K. M., Fu B., Ferraro F. et al., 1999. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort//Hypertension. Vol. 33. P. 1338-1341.
- O'Shaughnessy K. M., Fu B., Downing S. et al., 2001. Thrombophilic polymorphisms in pre-eclampsia: altered frequency of the functional 98C>T polymorphism of glycoprotein IIIa.//J. Med. Genet. Vol. 38. P. 775-777.
- Poort S. R., Rosendaal F. R., Reitsma P. H. et al., 1996. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis//Blood. V. 88. N 10. P. 3698-3703.
- Preston F. E., Rosendaal F. R., Walker I. D. et al., 1996. Increased fetal loss in women with heritable thrombophilia//Lancet. Vol. 348. N 9032. P. 913-916.
- Ridker P. M., Hennekens C. H., Schmitz C. et al., 1997. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis//Lancet. N. 349. P. 385-388.
- Sibai B. M., 2005. Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies?//Hypertension. Vol. 46. P. 1252-1253.
- Tempelhoff von G.-F., Heilmann L., Spanuth E. et al., 2000. Incidence of the factor V leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome//Thrombosis Research. Vol. 100. P. 363-365.
- Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S. E. et al., 1997. A сommon mutation (G-455>A) in the β-Fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease//J. Clin. Invest. Vol. 99. N 12. P. 3034-3039.
- Wiwanitkit V., 2006. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal//Arch Gynecol Obstet. Vol. 273. P. 322-324.
- Yalinkaya A., Erdemoglu M., Akdeniz N. et al., 2006. The relationship between thrombophilic mutations and preeclampsia: a prospective case-control study//AnnSaudi Me. Vol. 26. N 2. P. 105-109.
- Yamada N., Arinami T., Yamakawa-Kobayashi K. et al., 2000. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia//J. Hum. Genet. Vol. 45. P. 138-141.